Determinants of Response to a Cisplatin-Based Regimen as Neoadjuvant Chemotherapy in Stage IB-IIB Invasive Cervical Cancer

By Bolis G.   van Zainten-Przybysz I.   Scarfone G.   Zanaboni F.   Scarabelli C.   Tateo S.   Calabrese M.   Parazzini F.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 62-65

Academic Press

Access to resources Recommend Favorite

Prognostic Factors in Patients with Bulky Stage IB or IIA Cervical Carcinoma Undergoing Neoadjuvant Chemotherapy and Radical Hysterectomy

By Lai C.-H.   Hsueh S.   Chang T.-C.   Tseng C.-J.   Huang K.-G.   Chou H.-H.   Chen S.-M.   Chang M.-F.   Shum H.-C.  

Gynecologic Oncology, Vol. 64, Iss. 3, 1997-03 ,pp. : 456-462

Elsevier

Access to resources Recommend Favorite

Impact on Survival Following Successful Neoadjuvant Chemotherapy and Radical Surgery for Stage IIb Bulky and Stage IIIb Cervical Cancer

By Sugiyama T.   Hasuo Y.   Nishida T.   Kamura T.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 330-331

Elsevier

Access to resources Recommend Favorite

Neoadjuvant Intraarterial Chemotherapy Followed by Radical Hysterectomy and/or Radiotherapy for Locally Advanced Cervical Cancer

By Sugiyama T.   Nishida T.   Hasuo Y.   Fujiyoshi K.   Yakushiji M.  

Gynecologic Oncology, Vol. 69, Iss. 2, 1998-05 ,pp. : 130-136

Elsevier

Access to resources Recommend Favorite

High-Risk Group in Node-Positive Patients with Stage IB, IIA, and IIB Cervical Carcinoma after Radical Hysterectomy and Postoperative Pelvic Irradiation

By Aoki Y.   Sasaki M.   Watanabe M.   Sato T.   Tsuneki I.   Aida H.   Tanaka K.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 305-309

Elsevier

Access to resources Recommend Favorite